![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.36 | 23.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/6/2023 12:53 | when the seller clears the shares will trade materially higher. | ![]() purple11 | |
09/6/2023 12:52 | "So it was clever persuading Joanna Hart to ramp EDEN to give BGF the chance to partly escape" The BGF trade went through 6 days prior to the Daily Mil tip so what youve just written is complete rubbish! and thinking BGF have clandestine meetings with the Daily Mail really does show you up as a paranoid nutjob.!! | ![]() purple11 | |
09/6/2023 12:44 | purple11 Joanna Hart is a journalist and not afaiaa an investment expert.Even The Times Deputy Money Editor has only just started investing. Credit to Eden Management and Cenkos for somehow persuading Joanna Hart to tip Eden, bearing in mind the pathetic lack of sales for so many years. We now know why the share price didn’t go up following that National Newspaper tip. It gave BGF Investment Management the opportunity to dump a good chunk of their stake, and almost certainly at a big loss too. So it was clever persuading Joanna Hart to ramp EDEN to give BGF the chance to partly escape. Would BGF dump if believing the nonsense written by Joaana Hart that Eden share price should hit 19p again? She didn’t say why did she? The reality is that EDEN has up to now promised much and achieved very little beyond getting plenty of approvals and big name Partners. But EDEN has failed miserably to cash in on those plus points. Now unless they get sales going at long long long long last they will run out of money unless they can persuade clueless mugs to support yet another dilutive fund raising. Why do small investors fail to see what’s staring them in the face? Eden is a basket case unless they get sales at last. And that would be the time to buy. The chances of that happening look small but that’s the only hope for the many mugs who have held on to their EDEN shares for 20 years sometimes! Cleverer investors will buy on new genuine good news IF it ever comes. | ![]() kenmitch | |
09/6/2023 12:28 | The company has less than six months cash. It is no longer a going concern. The next few weeks do not look good unless there is a major fund raising. Don't encourage other mugs to join your poor investment decisions. | ![]() ravenna23 | |
09/6/2023 12:10 | "Eden shares are just 3.65p but they have been as high as 19p and should hit that level again, as the company has made huge progress in recent times and should reap the rewards this year and beyond." | ![]() purple11 | |
08/6/2023 11:02 | CITATION: "The Financial Conduct Authority (FCA) has today fined Cenkos Securities plc (Cenkos) £530,500 for failures in its sponsor services business. Cenkos failed to have appropriate systems and controls in place across its sponsor services business, and, on a particular transaction, failed to act in its sponsor role with the level of diligence and professional care that the FCA expects... Cenkos represented to the FCA that one of its clients was eligible for a Premium Listing when it had not carried out the requisite due diligence to ensure that this was correct. ... [because Cenkos immediately threw in the towel, pleading guilty, it] qualified for a 30% (stage 1) discount. Were it not for this discount, the FCA would have imposed a financial penalty of £757,800 on Cenkos." | ![]() neutralpov | |
08/6/2023 11:01 | STFU, you liar. Ferkwits like purple11 are designed to be screwed over. They serve no other purpose in the cycle of evolution, They can't even process that if this was a viable "investment", they wouldn't have to pay professional LIARS like stinkos to hype the pizzoshyte stock over the internet and in forums. Instead, people would be queuing up for the privilege to buy! (chortle, popcorn, watching the last embers of the BGF sellout pump die out and the share price fall back) --- Eden Research plc Official Classification by Stockopedia: SUCKER Stock (i.e., best suited for masochists, philanthropists and the criminally insane) TARGET share price : 0.00 pence (ZERO PENCE) | ![]() neutralpov | |
08/6/2023 08:03 | Biopesticides in Brazil Growth Rate Double Than United States or Europe 'It’s a broad range of products, but the key drivers are, number one, their regulatory system has gone through a number of changes over recent years, which has made it much easier to introduce products into that country. Five years ago or a little more, when we looked at biopesticides in Brazil, we saw a regulatory system where it routinely would take three to four years to bring a product to market. And today, you can bring a new product onto the market in less than a year. There are also government initiatives that support biologicals that assist companies that are starting up in this space, providing them with funding opportunities, through the government. But also, policies that encourage growers to use biologicals more frequently. All of these things are coming together'. 'Europe has a real challenge, because the introduction of microbial products, especially novel microbial products into Europe can routinely take a company five to 10 years to bring a new product. As a result, when we look around the world and see what percentage of the market is captured by microbial products, in the US and Brazil, it’s somewhere around 50% to 60% of the market is occupied by microbial based products. In Europe It’s more like 10% to 15%. It is a dramatic difference, and this is occurring at a time when Europe has other initiatives, where they’re trying to reduce the number of chemical pesticides available. So there are conflicting policies that the government is promoting, because on one hand they’re trying to remove chemicals, but they are not making it more friendly for biologicals to enter the market'. | ![]() supersonico | |
07/6/2023 18:36 | All which begs the question; Is the delete-lube-fella who can't say Cedroz.. now a fella who can't see Ecovelex? | ![]() supersonico | |
07/6/2023 17:56 | With Eden's history of ....in the coming...and Smith's well learned caution on predicting regulatory outcomes it's hard not to judge the numerous mentions of '2024 growing season' in the AR for Ecovelex seed treatment as a done deal otherwise one would expect a way more heavily caveated approach. | ![]() supersonico | |
07/6/2023 16:21 | purple11 7 Jun '23 - 09:31 - 14281 > what an utterly pathetic life you must lead if this is all you can do everyday! It isn't all, or even 2%, of what I do. But isn't it commendable that I altruistically warn fools about being parted from their money? When it eventually dawns on you that I am 100% correct, and you've just contributed to someone else's lifestyle company and personal pension plan, will you have the decency to crawl to me with an apology before crawling off to the railway tracks? | ![]() neutralpov | |
07/6/2023 16:05 | ?? Researchers research. Informers inform. Try to grasp the basics. | ![]() neutralpov | |
07/6/2023 15:55 | Neuts l would have thought you would have got your researcher to contact them? | ![]() timbo_slice | |
07/6/2023 15:35 | Brucie5, do not in future converse with the mentally-ill (supersonico) and filth (investingisatrickyg Or does BGF preferring receiving 3.5p to receiving 0p REALLY surprise you?? @@ Timbo_Slice 7 Jun '23 - 14:22 - 14290 > They [BGF] either no longer believe in the investment case (0 pence). You should have stopped there and, for once, been correct. Surely you realise I've been in touch, don't you? Sheesh. > They see opportunity elsewhere and are rebalancing their investment (A.N.Other Share). Since any opportunity whatever is likely to be better than the certainty of losing all all their money ""invested"", that really didn't need stating, ijjit! > They believe they can buy back at lower (placing). What an absolutely pathetic and idiotic ramp attempt that was. Change your medication. | ![]() neutralpov | |
07/6/2023 14:22 | They either no longer believe in the investment case (0 pence).They believe they can buy back at lower (placing).They see opportunity elsewhere and are rebalancing their investment (A.N.Other Share). | ![]() timbo_slice | |
07/6/2023 14:06 | Super and Investing - I don't doubt what you say, which is why my own decision making here is on a knife edge - if you'll pardon the pun. The investment case remain asymmetric afaic, but the funding uncertainty leaves me uneasy for the time being. I take it axiomatic that small companies seeking extra cash always seek to surprise, for obvious reasons. They merely have to reassure, with figures, clearly and unambiguously, and I may well be back. In the meantime, why do we think BGF reduce so heavily? I'm thinking this was a thumping loss, if the stake was taken at the 6p raising? | ![]() brucie5 | |
07/6/2023 13:30 | The disgusting lying paed0 RAMPER Investingisatrickyga > [SNIP!!!!!!!!!!!!!!! > It is not going to take very much from the above to put Eden into profit and in my opinion, the chances are significant profit in the not too distant future. Ferkin' liar, tricking brainless mugs like purple11. When we get you convicted of breaches of FSMA2000 (your undisclosed remuneration for ramping this PoS will do you down - we have ways of ensuring a suitable HC Judge picks up the ticket) I will take personal pleasure in arranging your accommodation at His Majesty's Pleasure, and hoping that your cellmate Sambo has urgent recurring "special needs". Know what I mean, biatch? | ![]() neutralpov | |
07/6/2023 13:25 | SupeARich, good question. JakNife beat me to answering it. JakNife 7 Jun '23 - 10:48 - 14283 > Eden would need ... in order to breakeven ... revenue needs to grow by 310% LOL! Yes. i.e., EDEN will NEVER be able to manage this. Worse, of course, it also has to recoup the massive accumulated past costs its previous auditors have permitted it to capitalise So Hell plc (a better name than Eden plc) needs to do a lot better than merely break-even to become viable. BTW, my version of the same calculation, slightly different assumptions, predict EDEN would need to up its sales to 520% of the current level (i.e., say an increase by 419%, what a fitting number!) in order to break-even. RESTATED TARGET PRICE EDEN Research plc ... ZERO PENCE (0.00p) | ![]() neutralpov | |
07/6/2023 12:44 | SupeARich said "There's always some possibility BUT how much actual Business growth is it realistically going to take and what might the associated timescales look like?" The following should answer your questions. I believe Eden burns around £2.5 million ish. operational costs per annum Corteva Business 28/2/2020 RNS under "The Corteva Agreement" Circa €40 million p.a. hxxps://polaris.brig 2/3/2022 RNS under "Corteva" €20 million in the short term following launch hxxps://polaris.brig Insecticide " first sales of our insecticides in the US in 2024/2025" AND "Eden stands amongst very few British crop protection companies to obtain approvals for multiple biopesticides in the US. The market potential in the US for Mevalone® and Cedroz™ alone stands at approximately €94 million and €189 million per annum, respectively. This excludes the opportunities for bioinsecticides which are estimated to be worth an additional €237 million." Source: 5th May 2023 RNS hxxps://polaris.brig Cenkos Forecasts hxxps://www.edenrese It is not going to take very much from the above to put Eden into profit and in my opinion, the chances are significant profit in the not too distant future. | ![]() investingisatrickygame | |
07/6/2023 12:24 | With Corteva M&A action around biologicals .. acquiring Symborg and Stoller last year.. these acquisitions make Corteva one of the most significant biological players globally. They state at every opportunity that biologicals will make up 25% of the crop protection market by 2035. They also predict this will make the biological market a $30 billion juggernaut. One commentator I read recently said Corteva has been historically weak in seed treatment which indicates to this whale watcher that Eden is very important to Corteva's strategic ambitions. | ![]() supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions